Essen Speciality Films Ltd

Essen Speciality Films Ltd

₹ 662 4.91%
16 Oct - close price
About

Incorporated in 2002, Essen Speciality
Films Ltd manufactures plastic and home
décor products[1]

Key Points

Business Overview:[1][2][3]
ESFL is a part of the Rajoo Group. It manufactures plastic articles mainly for global furnishing companies. The plastic articles are modified and tailor-made as per customer requirements. Company manufactures ethylene
vinyl acetate (EVA) and low-density polyethylene (LDPE) based articles for various application

  • Market Cap 1,370 Cr.
  • Current Price 662
  • High / Low 662 / 135
  • Stock P/E 105
  • Book Value 69.1
  • Dividend Yield 0.11 %
  • ROCE 17.8 %
  • ROE 12.7 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 9.57 times its book value
  • Company has a low return on equity of 11.6% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Plastic products Industry: Plastics Products

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
28.14 21.40 33.03 36.11 30.60 34.00 37.56 40.16 34.55
24.61 18.85 26.18 29.21 24.51 26.81 30.54 36.89 30.52
Operating Profit 3.53 2.55 6.85 6.90 6.09 7.19 7.02 3.27 4.03
OPM % 12.54% 11.92% 20.74% 19.11% 19.90% 21.15% 18.69% 8.14% 11.66%
0.31 0.25 0.49 0.75 0.43 0.46 0.68 0.79 0.67
Interest 0.64 0.76 0.61 0.61 0.36 0.78 0.41 0.14 0.14
Depreciation 0.91 0.94 0.95 0.94 1.33 1.38 1.37 1.34 1.34
Profit before tax 2.29 1.10 5.78 6.10 4.83 5.49 5.92 2.58 3.22
Tax % 16.16% 25.45% 28.20% -20.00% 25.26% 25.14% 22.97% 23.64% 26.71%
1.92 0.82 4.15 7.32 3.61 4.11 4.56 1.96 2.37
EPS in Rs 1.20 0.51 2.59 4.58 2.26 1.99 2.20 0.95 1.14
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
73 96 118 119 143 146
58 77 105 99 118 125
Operating Profit 15 18 13 21 24 22
OPM % 20% 19% 11% 17% 17% 15%
1 1 1 1 2 3
Interest 1 1 3 3 2 1
Depreciation 3 6 4 4 5 5
Profit before tax 11 13 7 15 19 17
Tax % 27% 25% 68% 7% 24%
8 9 2 14 14 13
EPS in Rs 79.50 94.80 1.41 8.88 6.88 6.28
Dividend Payout % 31% 21% 0% 0% 11%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 14%
TTM: 21%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 15%
TTM: -18%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 343%
Return on Equity
10 Years: %
5 Years: %
3 Years: 12%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 1 1 16 16 21
Reserves 59 68 55 69 122
4 15 26 7 0
11 23 22 18 10
Total Liabilities 76 108 119 110 153
41 41 0 43 41
CWIP 0 0 0 0 0
Investments 0 0 0 0 1
35 66 118 66 110
Total Assets 76 108 119 110 153

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
7 15 -15 25 -3
-2 -23 6 -3 -28
-6 8 8 -22 35
Net Cash Flow -0 -0 -2 0 4

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 38 53 45 52 49
Inventory Days 80 104 137 190 167
Days Payable 26 82 53 65 18
Cash Conversion Cycle 93 75 128 176 198
Working Capital Days 128 131 163 133 159
ROCE % 18% 11% 18% 18%

Shareholding Pattern

Numbers in percentages

10 Recently
Sep 2023Dec 2023Mar 2024Jun 2024
70.05% 70.07% 70.09% 70.10%
2.63% 0.79% 0.60% 0.60%
3.43% 2.30% 2.30% 2.30%
23.89% 26.84% 27.02% 27.00%
No. of Shareholders 1,9321,9461,8562,089

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents